Anteris Technologies Global (NASDAQ:AVR) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Anteris Technologies Global (NASDAQ:AVR) announced its quarterly earnings results on Tuesday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01), FiscalAI reports. The company had revenue of $0.49 million for the quarter, compared to the consensus estimate of $0.77 million. Anteris Technologies Global had a negative net margin of 4,921.27% and a negative return on equity of 536.04%.

Anteris Technologies Global Trading Up 2.9%

NASDAQ:AVR traded up $0.19 during mid-day trading on Tuesday, hitting $6.70. 562,861 shares of the company’s stock were exchanged, compared to its average volume of 1,098,858. The company has a 50 day simple moving average of $5.91 and a 200-day simple moving average of $5.32. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.01. Anteris Technologies Global has a fifty-two week low of $2.85 and a fifty-two week high of $6.95. The firm has a market capitalization of $651.44 million, a P/E ratio of -2.62 and a beta of 1.32.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AVR. Wells Fargo & Company began coverage on shares of Anteris Technologies Global in a report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price target on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.00 price target on shares of Anteris Technologies Global in a report on Friday, March 27th. Finally, Lake Street Capital reaffirmed a “buy” rating and set a $15.00 price target on shares of Anteris Technologies Global in a report on Friday, January 23rd. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $15.33.

Institutional Investors Weigh In On Anteris Technologies Global

Several hedge funds have recently added to or reduced their stakes in AVR. Russell Investments Group Ltd. lifted its position in shares of Anteris Technologies Global by 76.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock worth $29,000 after purchasing an additional 2,841 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Anteris Technologies Global in the 1st quarter worth approximately $32,000. BNP Paribas Financial Markets lifted its position in shares of Anteris Technologies Global by 83.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock worth $43,000 after purchasing an additional 4,302 shares during the period. Bank of America Corp DE lifted its position in shares of Anteris Technologies Global by 35.7% in the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after purchasing an additional 2,798 shares during the period. Finally, Intech Investment Management LLC acquired a new position in shares of Anteris Technologies Global in the 4th quarter worth approximately $67,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.